Prosecution Insights
Last updated: April 19, 2026

Examiner: BAKSHI, PANCHAM

Tech Center 1600 • Art Units: 1621 1623 1671 1673

This examiner grants 77% of resolved cases

Performance Statistics

77.1%
Allow Rate
+17.1% vs TC avg
1209
Total Applications
+30.4%
Interview Lift
891
Avg Prosecution Days
Based on 1132 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
23.0%
§102 Novelty
32.0%
§103 Obviousness
27.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18111103 IMMUNOMODULATORY OLIGOSACCHARIDES Final Rejection The Regents of the University of California
18107936 IMMUNOMODULATORY OLIGOSACCHARIDES Final Rejection The Regents of the University of California
18304396 LOW DOSE COMBINATION CDA SUBSTRATE DRUG/CEDAZURIDINE WITH EXTENDED ADMINISTRATION Final Rejection Otsuka Pharmaceutical Co., Ltd.
17801715 METHOD FOR REDUCING NUCLEIC ACID AND ADSORBING FILTER Final Rejection KANEKA CORPORATION
17639552 THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING COMBINATION MEDICINE Non-Final OA Japan Tobacco Inc.
18001184 FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY Non-Final OA UNIVERSITÉ PARIS CITÉ
18282263 METHOD FOR PRODUCING OXIDE AND METHOD FOR PRODUCING PT/BI COMPOSITE CATALYST Non-Final OA KAO CORPORATION
17608103 METHODS AND COMPOSITIONS FOR SENSITIZING CANCER CELLS TO DRUG-INDUCED APOPTOSIS Final Rejection New York University
17998831 PRODUCTION PROCESS FOR AMINO ALCOHOLATES Final Rejection Covestro Deutschland AG
18980692 METHODS AND SYSTEMS FOR FORMING A LAYER COMPRISING SILICON AND COMPOSITION AND SYNTHESIS OF SILICON PRECURSOR Non-Final OA ASM IP Holding B.V.
18194805 GOLD NONOCLUSTERS, DOPAMINE BIOSENSORS INCLUDING THEM, AND METHODS FOR DIAGNOSING NEUROLOGICAL DISEASES USING THE SAME Non-Final OA Industry-Academic Cooperation Foundation, Yonsei University
18328049 Skin Care Compositions and Methods of Use Non-Final OA Colgate-Palmolive Company
18197150 N-ALKYL SUBSTITUTED CYCLIC AND OLIGOMERIC PERHYDRIDOSILAZANES, METHODS OF PREPARATION THEREOF, AND SILICON NITRIDE FILMS FORMED THEREFROM Non-Final OA Gelest, Inc.
18276675 IMPROVED PROCESS FOR MANUFACTURING HIGH-PURITY ALKYL ACRYLATES Non-Final OA Arkema France
17436023 COMPOSITIONS OF MATTER WITH ACTIVITY TO REMOVE LIPOFUSCIN FROM RETINAL CELLS Non-Final OA Cornell University
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION Final Rejection Keygene N.V.
18041582 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND Final Rejection KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
18618489 ALGINATE LIQUID PREPARATION Final Rejection MOCHIDA PHARMACEUTICAL CO., LTD.
17754976 SOLUBLE CORN STEEP Final Rejection ROQUETTE FRERES
18036629 MONO-TIN ORGANIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Non-Final OA ANHUI JINHE INDUSTRIAL CO., LTD.
18246569 TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE Non-Final OA TX MEDIC AB
18550845 A PROCESS FOR THE PREPARATION OF MIXED OXYBATE SALTS AND POLYMORPHS THEREOF Non-Final OA ALKEM LABORATORIES LIMITED
18368435 PROCESSING LIPID-CONTAINING COMPOUNDS FOR FUEL FEEDSTOCK THROUGH ACID DEGUMMING AND ADSORPTIVE BLEACHING/DRYING Non-Final OA OLEO-X LLC
18328417 REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES Non-Final OA UNIVERSITÉ DE CAEN NORMANDIE
18195937 1,1,1-TRIS(ORGANOAMINO)DISILANE COMPOUNDS AND METHOD OF PREPARING SAME Non-Final OA Jiangsu Nata Opto-Electronic Materials Co. Ltd.
18313032 CHIRAL CONTROL Non-Final OA WAVE LIFE SCIENCES LTD.
17624516 COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES Final Rejection ADS THERAPEUTICS LLC
18031243 FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF Non-Final OA EAST CHINA NORMAL UNIVERSITY
17442217 COMPOSITIONS AND METHODS FOR INCREASING T CELL FUNCTION Final Rejection LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.
17817267 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES Non-Final OA AM Chemicals LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month